[1] 廖华.缓控释制剂简介[J].湖北中医杂志,2008,30(12):51.
[2] Rane AB, Gattani SG, Kadam VD,et al. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers[J].Chem Pharm Bull (Tokyo),2009,57(11):1213.
[3] 杨金有.生物节律与合理用药[J].中国实用医药,2010,5(5):241.
[4] 袁源,刘保安.昼夜节律与肿瘤的相关研究进展[J].现代生物医学进展, 2009,9(5):976
[5] Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics[J].Adv Drug Deliv Rev,2007,59(9-10):828.
[6] Youan BB.Chronopharmaceutics:gimmick or clinically relevant approach to drug delivery? [J].J Control Release,2004,98(3):337.
[7] 丛绍强,王延文,王智亮.中药时辰药理学的研究进展[J].泰山卫生,2005,29(1):11.
[8] 潘颖,杨劫.脉冲释药系统[J].河北医药,2005,27(11):862.
[9] Lin HL, Lin SY, Lin YK, et al. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling[J]. Eur J Pharm Biopharm, 2008,70(1):289.
[10] Fan TY, Wei SL, Yan WW, et al.An investigation of pulsatile release tablets with ethylcellulose and Eudragitl as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets[J].J Control Release,2001,77(3):245.
[11] Gao C, Huang J, Jiao Y, et al. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets[J]. Int J Pharm, 2006,322(1-2):104.
[12] 许建辰.微囊化技术用于脉冲给药系统的研究[D].天津大学,2005.
[13] He W, Du Q, Cao DY, et al. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats[J]. Int J Pharm,2008,348(1-2):35.
[14] 侯世祥,杜守颖,夏新华,等.现代中药制剂设计理论与实践[M].北京:人民卫生出版社,2010.620.
[15] Efentakis M, Koligliati S, Vlachou M.Design and evaluation of a dry coated drug delivery system with an impermeable cup, swellable top layer and pulsatile release[J].Int J Pharm,2006,311 (1-2):147.
[16] 谢燕,马越鸣,李国文.口服脉冲控释给药系统的释药机制及其应用[J].中国医药工业杂志,2011,42(1):60.
[17] 施祥杰,周建平.胃内滞留释药系统的研究新进展[J].药学进展,2010,34(2):55.
[18] Miyazaki Y, Ogihara K, Yakou S, et al. In vitro and in vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate[J].Int J Pharm,2003,258 (1-2):21.
[19] 邹豪,孔令山,谢明萱.漂浮型脉冲释放胶囊的人体内γ-闪烁扫描示踪研究[J].中国医药工业杂志,2004,35(12):724.
[20] 唐宇,罗杰英,王文苹.胃内膨胀型制剂的研究进展[J].中国新药杂志,2009,18(14):1304.
[21] Park K, Chen J, Park H. Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties[P].US, 6271278, 2001-08-07.
[22] 郭涛,周俭平,隋因,等.硫酸沙丁胺醇脉冲片的制备及体外释放度研究[J].中国药学杂志,2000,35(6):388.
[23] 杨正管,朱家壁,刘锡钓.茶碱脉冲式控释片的研制[J].中国医院药学杂志,1998,18(11):483.
[24] 匡玉霞,刘生友.心血管疾病的昼夜节律与时辰给药[J].中国药师,2010,13(10):1514.
[25] 孙学惠,郭涛,宋洪涛,等.单硝酸异山梨酯定时脉冲控释片的研究[J].解放军药学学报,2005,21(4):258.
[26] 吴芳,张志荣,何伟玲,等.磷酸川芎嗪脉冲塞胶囊的制备与体外释放[J]. 药学学报,2002,37(9):733.
[27] 陈燕忠,岗艳云,金志忠,等.法莫替丁脉冲控释胶囊剂的研究[J].中国药科大学学报,1997,28(3):150.
[28] 曹赛宏.浅谈糖皮质激素的合理应用[J].安庆医学,2005,26(1):6.
[29] 郭涛,郑春丽,宋洪涛,等.双氯芬酸钠脉冲控释微丸的研究[J].药学学报,2003,38(9):707.
[30] 郑春丽,郭涛,宋洪涛,等.双氯芬酸钠脉冲控释微丸的制备与体外释放影响因素的研究[J].中国药学杂志,2003,38(2):111.
[31] 安娜.栓塞控制型盐酸维拉帕米双脉冲胶囊的研制[D].河北医科大学,2010.
[32] 胡文静,张良珂,刘静.含果胶盖塞型脉冲胶囊的制备及体外释放研究[J]. 中国药学杂志,2009,44(9):685.
[33] 刘伟芬,张会丽.硝苯地平脉冲释放微丸的试制[J].中国中医药现代远程教育,2010,8(14):201.
[34] 梁雪丹,郑颖,范田园.丹参酮ⅡA脉冲微丸的制备与体外质量评价[J]. 北京大学学报,2010,42(5):559.
[35] 屈勇,张怡,林宁.丹参口服脉冲控释片的制备及体外释药研究[J].湖北中医学院学报,2010,12(6):24.
[36] 逄凤娟,邹梅娟,刘国良,等.盐酸伪麻黄碱脉冲小片包衣液处方优化[J].沈阳药科大学学报,2009,26(3):170.